Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

Researchers are gaining new insights into neurological diseases by studying circular RNAs (circRNAs) in brain cells.

19 Sep 2023

Broken String Biosciences closes $15M series A funding round

Broken String Biosciences today announced that it has closed a $15 million Series A investment round.

From Broken String Biosciences 18 Sep 2023

MGI and Bio-Medical Science sign MOU to deliver cutting-edge sequencing platforms and reagents to South Korea

MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions in South Korea by leveraging MGI's cutting-edge technology.

From MGI 18 Sep 2023

MGI's innovative technologies Is enabling sequencing of first plant species in the African BioGenome project

MGI, a company committed to building core tools and technology to lead life science, is delighted to support The African BioGenome Project (AfricaBP), launched in 2021, in sequencing of the project's first plant species based on MGI's DNBSEQ-G400* versatile benchtop sequencer and single-tube long fragment read (stLFR) technology.

From MGI 18 Sep 2023

MGI introduces new chapter in smart laboratory management with official opening of αLab in HKSTP

MGI, a company committed to building core tools and technology to lead life science, today announced the official opening of αLab in the Hong Kong Science & Technology Parks ("HKSTP"), the city's largest R&D base and one of the most important incubators.

From MGI 18 Sep 2023

Genetic sequencing shows promise as first-tier newborn screening test

Newborn screening (NBS) is routinely performed across the world using biochemical testing methods. Recent advancements in genetic sequencing are a potential game-changer for newborn screening, swiftly assessing a comprehensive range of monogenic disorders.

14 Sep 2023

JAX offers a fully validated, clinical whole genome sequencing test

Until quite recently, it was extremely difficult to detect the variants underlying many genetic disorders. In the absence of a defined cause, clinicians have little to guide treatment for those left without a genetic diagnosis, forcing patients and families to embark on a diagnostic odyssey with no guarantee of finding answers.

14 Sep 2023

Multi-omics study offers insights into psoriasis treatment

Researchers use a multi-omics approach combining immune cell-enriched scRNA-seq, microarray analysis, and immunohistochemistry to elucidate the translational role of anti-IL-17A in suppressing the autoimmune functions of T17 cells, thereby effectively treating human psoriasis.

14 Sep 2023

Nine-year study reveals lipids' pivotal role in aging, health, and disease

This groundbreaking nine-year study used advanced mass spectrometry to analyze lipid profiles in human plasma, revealing dynamic changes tied to aging, insulin resistance, and viral infections. The findings suggest that specific lipid subclasses are crucial indicators and potential targets for treatment in human health and various diseases.

13 Sep 2023

Innovative technique provides unparalleled insight into autism pathology

Does the human brain have an Achilles heel that ultimately leads to Autism? With a revolutionizing novel system that combines brain organoid technology and intricate genetics, researchers can now comprehensively test the effect of multiple mutations in parallel and at a single-cell level within human brain organoids.

13 Sep 2023

Researchers receive £2.66M to test new immunotherapeutic strategy for non-small cell lung cancer

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the most deadly cancers.

13 Sep 2023

UC Riverside study uncovers COVID's Achilles heel

New UC Riverside research has revealed COVID's Achilles heel - its dependence on key human proteins for its replication - which can be used to prevent the virus from making people sick.

13 Sep 2023

AfricaBP aims to foster grassroots knowledge exchange in biodiversity genomics and bioinformatics

Since its inception in 2021, the African BioGenome Project (AfricaBP), has made significant gains towards its ambitious goal of sequencing 100,000 endemic African species within the next 10 years.

13 Sep 2023

Customized diets: The future of disease management revealed in gut study

The interactions between individual diets and the gut microbiome.

13 Sep 2023

Australian researchers uncover new genetic insights into Staphylococcus aureus bacteremia

Australian researchers have uncovered new genetic insights into Staphylococcus aureus, revealing what makes the bacterium so dangerous when it enters the blood.

12 Sep 2023

Mount Sinai researchers identify the structure of a special red blood cell transporter

Researchers at the Icahn School of Medicine at Mount Sinai have identified the structure of a special transporter found in red blood cells and how it interacts with drugs.

8 Sep 2023

Mount Sinai and BCRI partner to improve cardiovascular health and education in Latin America

Icahn School of Medicine at Mount Sinai announced today that it has signed a memorandum of understanding with the Brazilian Clinical Research Institute (BCRI) to focus on advancing cardiovascular disease research, innovation, and medical education.

8 Sep 2023

How is next-generation protein sequencing democratizing protein sequencing?

In this interview, NewsMedical speaks with Jeff Hawkins, CEO of Quantum-Si, about the challenges of conventional proteomic methods, as well as how next-generation protein sequencing is democratizing protein sequencing.

From Quantum-SI 5 Sep 2023

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

llumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., as Chief Executive Officer, effective September 25, 2023.

From Illumina, Inc. 5 Sep 2023

NGS-based screening identifies rare and novel thalassemia mutations in Ganzhou, China

Around 5.2% of the global population carries abnormal hemoglobin genes. Each year, 300,000 to 500,000 children are born with severe hemoglobinopathies worldwide, with approximately 80% of these cases occurring in developing countries.

5 Sep 2023

Genomics News and Research

Further Reading

Gaining new insights into neurological diseases by studying circular RNAs in brain cells

Broken String Biosciences closes $15M series A funding round

MGI and Bio-Medical Science sign MOU to deliver cutting-edge sequencing platforms and reagents to South Korea

MGI's innovative technologies Is enabling sequencing of first plant species in the African BioGenome project

MGI introduces new chapter in smart laboratory management with official opening of αLab in HKSTP

Genetic sequencing shows promise as first-tier newborn screening test

JAX offers a fully validated, clinical whole genome sequencing test

Multi-omics study offers insights into psoriasis treatment

Nine-year study reveals lipids' pivotal role in aging, health, and disease

Innovative technique provides unparalleled insight into autism pathology

Researchers receive £2.66M to test new immunotherapeutic strategy for non-small cell lung cancer

UC Riverside study uncovers COVID's Achilles heel

AfricaBP aims to foster grassroots knowledge exchange in biodiversity genomics and bioinformatics

Customized diets: The future of disease management revealed in gut study

Australian researchers uncover new genetic insights into Staphylococcus aureus bacteremia

Mount Sinai researchers identify the structure of a special red blood cell transporter

Mount Sinai and BCRI partner to improve cardiovascular health and education in Latin America

How is next-generation protein sequencing democratizing protein sequencing?

Illumina's board appoints Jacob Thaysen, Ph.D. as its new Chief Executive Officer

NGS-based screening identifies rare and novel thalassemia mutations in Ganzhou, China

NGS for Infectious Disease Surveillance eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo